BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Lymphocyte
,
Avian flu virus
,
Trichostatin A
,
rs2300478
,
ERBB2
,
cell-cell adhesion
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
CPT2
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Liver
Colon mucosa
Colon
Kidney cortex
Oral mucosa
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Carnitine deficiency
Muscle cachexia
Deficiency state
Pyloric ulcer
Bacterial infectious disease
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Carnitine
2-ethoxy-3-(4-((4-(methylsulfonyloxy)phenethyl)oxy)phenyl)propanoic acid
aleglitazar
Perhexiline
Roxarsone
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
RNA15
SACM1L
OLR1
GK
PPARA
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Adult-onset carnitine palmitoyl transferase II (CPT II) deficiency presenting with rhabdomyolysis an…
Successful orthotopic heart transplantation in CPTII deficiency.
Whole-Exome Sequencing Identifies a Novel CPT2 Mutation in a Pedigree With Gout.
Imipramine activates FAM3A-FOXA2-CPT2 pathway to ameliorate hepatic steatosis.
CPT2-mediated fatty acid oxidation inhibits tumorigenesis and enhances sorafenib sensitivity via the…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Bezafibrate Trial in CPT2 Deficiency
Fatty Acid Oxidation Disorders & Body Weight Regulation Grant
Study of Triheptanoin for Treatment of Long-Chain Fatty Acid Oxidation Disorder
Nutritional Therapy of the Deficits of Oxidation Mitochondrial of the Fatty Acids
Compassionate Use of Triheptanoin (C7) for Inherited Disorders of Energy Metabolism
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ